Latest News

Nevada expands syringe vending machines with naloxone, fentanyl strips; anonymity critical for uptake.

Q3 2022 review of HCV drug access across ADAPs, Medicaid, and comprehensive harm reduction programs.

NIH issues RFAs for Harm Reduction Network; Biden agenda targets decriminalization and safe consumption.

31,000 Veterans with HIV face unique barriers including comorbidities and HCV rates 3x the general population.

COVID-19 strains public health efforts addressing HIV outbreaks, diverting resources from the domestic epidemic.

Q3 2021 quarterly review of HCV drug access across ADAPs and Medicaid with harm reduction program updates.

Analysis of Kanawha County HIV outbreak highlighting substance use, rural healthcare gaps, and pandemic impact.

NASTAD's hepatitis C navigation toolkit uses peer navigators and wraparound services for people who use drugs.

Quarterly Watch covering HCV treatment access across ADAPs and Medicaid, harm reduction programs, and COVID-19 impact on care.